Correlation Between Traws Pharma and US Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Traws Pharma and US Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Traws Pharma and US Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Traws Pharma and US Global Investors, you can compare the effects of market volatilities on Traws Pharma and US Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Traws Pharma with a short position of US Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Traws Pharma and US Global.

Diversification Opportunities for Traws Pharma and US Global

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Traws and GROW is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Traws Pharma and US Global Investors in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Global Investors and Traws Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Traws Pharma are associated (or correlated) with US Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Global Investors has no effect on the direction of Traws Pharma i.e., Traws Pharma and US Global go up and down completely randomly.

Pair Corralation between Traws Pharma and US Global

Given the investment horizon of 90 days Traws Pharma is expected to generate 40.21 times more return on investment than US Global. However, Traws Pharma is 40.21 times more volatile than US Global Investors. It trades about 0.17 of its potential returns per unit of risk. US Global Investors is currently generating about 0.1 per unit of risk. If you would invest  520.00  in Traws Pharma on October 5, 2024 and sell it today you would earn a total of  347.00  from holding Traws Pharma or generate 66.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Traws Pharma  vs.  US Global Investors

 Performance 
       Timeline  
Traws Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Traws Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Traws Pharma showed solid returns over the last few months and may actually be approaching a breakup point.
US Global Investors 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US Global Investors has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, US Global is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Traws Pharma and US Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Traws Pharma and US Global

The main advantage of trading using opposite Traws Pharma and US Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Traws Pharma position performs unexpectedly, US Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Global will offset losses from the drop in US Global's long position.
The idea behind Traws Pharma and US Global Investors pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stocks Directory
Find actively traded stocks across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios